Status:
RECRUITING
AIMS Medical Outcomes Study
Lead Sponsor:
Advanced Integrative Medical Science Institute
Conditions:
Mental Health Issue
PTSD
Eligibility:
All Genders
Brief Summary
This epidemiologic research is being conducted as an observational prospective case series outcomes study of the use of advanced integrative specialty medical care and its effect on adult and pediatri...
Detailed Description
There is growing interest in providing integrative medical care in conjunction with specialty medical care to expand the reach of integrative care to more chronically and seriously ill patient populat...
Eligibility Criteria
Inclusion
- Patients enrolled in the study will meet the following criteria:
- A new patient coming in for a first office call (FOC) or first consultation via telemedicine with an AIMS physician or advanced practice provider;
- An established patient;
- If over 18 years of age are able to understand study design adequately and provide signed informed consent to enrollment;
- If younger than 18 years of age informed consent from a parent or guardian who is able to understand the study design adequately and provide signed informed consent for the pediatric patient.
Exclusion
- Ineligible participants:
- Cannot read or understand English well enough to read and sign the consent form and complete the questionnaires;
- Unwilling to participate in the AIMS Institute observational study.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04512755
Start Date
July 1 2020
End Date
December 31 2030
Last Update
February 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AIMS Institute
Seattle, Washington, United States, 98102